Microbiota Modulation in Food Allergy Mechanisms

Food allergy arises from a breakdown in immune tolerance to dietary antigens, a process in which the gut microbiota exerts critical influence. In health, a diverse microbial community supports epithelial barrier integrity, educates dendritic cells and fosters regulatory T cell differentiation. Perturbations in microbial composition—termed dysbiosis—can impair barrier function, skew T helper 2 (Th2) responses and reduce production of key metabolites such as short-chain fatty acids (SCFAs). SCFAs, particularly butyrate, acetate and propionate, regulate mucosal immunity through epigenetic and metabolic pathways, enhancing regulatory pathways and suppressing allergic inflammation. Specific taxa, including Clostridia clusters and Bifidobacterium species, have been linked to oral tolerance, while expansion of mucin-degrading or pro-inflammatory bacteria can exacerbate allergic sensitisation. Strategies to modulate microbiota range from dietary fibres and prebiotics to live biotherapeutics and targeted metabolite delivery. Preclinical and early clinical studies highlight the potential for microbiota-based interventions to restore homeostasis, prevent sensitisation and accelerate tolerance acquisition, underscoring their global significance for allergy prevention and management.

Research from Nature Portfolio

Recent studies demonstrate diet-microbiota interactions in food allergy. In murine models, deprivation of dietary fibre fosters expansion of a mucin-degrading bacterium, triggering barrier dysfunction, elevated type 1 and type 2 cytokines and heightened IgE responses to common allergens. Restoration of fibre or targeted manipulation of microbial consortia attenuates allergic reactions. Complementing this, engineered polymeric micelles have been designed to release butyrate in the gut, selectively enriching butyrate-producing Clostridia. Oral administration of these micelles in peanut-allergic mice re-establishes barrier integrity, increases regulatory mediators and prevents anaphylaxis, illustrating an antigen-agnostic, metabolite-focused therapeutic approach.

Microbiota Modulation in Food Allergy Mechanisms publication trend

The graph below shows the total number of articles in microbiota modulation in food allergy mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Dysbiosis: Disruption of the normal balance and diversity of the gut microbial community.

Oral tolerance: Immune unresponsiveness to antigens introduced via the gastrointestinal tract.

Short-chain fatty acids (SCFAs): Microbial fermentation products (acetate, propionate, butyrate) that regulate mucosal immunity.

Gnotobiotic: Pertaining to organisms or models with a defined or germ-free microbiota composition.

Polymeric micelles: Nanoscale carriers designed to deliver bioactive compounds, such as butyrate, to specific regions of the intestine.

References

1. Akkermansia muciniphila exacerbates food allergy in fibre-deprived mice. Nature Microbiology (2023).
2. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. The ISME Journal: Multidisciplinary Journal of Microbial Ecology (2015).
3. The Relationship between the Infant Gut Microbiota and Allergy. The Role of Bifidobacterium breve and Prebiotic Oligosaccharides in the Activation of Anti-Allergic Mechanisms in Early Life. Nutrients (2020).
4. Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy. Frontiers in Immunology (2020).
5. Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles. Nature Biomedical Engineering (2022).